Breakthrough SARS-CoV-2 Omicron Variant in Individuals Primed with Heterologous Vaccines Enhances Inhibition Performance of Neutralizing Antibody to BA.2 Parental Lineage

Breakthrough SARS-CoV-2 Omicron Variant in Individuals Primed with Heterologous Vaccines Enhances Inhibition Performance of Neutralizing Antibody to BA.2 Parental Lineage

This study aims to analyze the neutralization ability against Omicron parental variants in five clusters of individuals with different Coronavirus disease (COVID-19) immunity backgrounds, including individuals receiving a homologous or heterologous vaccine without prior infection, recovered patients...

Full description

Bibliographic Details
Main Authors: Jidapa Szekely, Piyawut Swangphon, Natthaphon Nanakorn, Panuttha Chaimuti, Teerapat Nualnoi, Paweena Wongwitwichot, Namchoke Somapa, Denpong Somapa, Theerakamol Pengsakul
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Vaccines
Subjects:
COVID-19
neutralizing antibodies
homologous vaccine
heterologous vaccine
Omicron variants
Online Access:https://www.mdpi.com/2076-393X/11/7/1230

Internet

https://www.mdpi.com/2076-393X/11/7/1230

Similar Items